Sponsor Pipeline

Terns, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT06163430
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and…		 Sponsor changed: Terns, Inc. -> Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06163430 A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and… Chronic Myeloid Leukemia, Chronic Phase Recruiting
Disease Areas
Leukemia (1) Chronic Myeloid Leukemia (CML) (1)
Get alerts when Terns, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free